U.S. FDA Holds Off Decision on Moderna’s COVID-19 Vaccine for Teens

2 Mins read

The U.S. Food and Drug Administration has postponed approving the Moderna COVID-19 vaccine for 12 to 17-year-olds. The FDA will be holding off on approval at least until January 2022. Of course, mighty slots casino all being just a tap of your iPads screen away.  

A statement by Moderna clarified that the delay was related to further analysis of emerging international data of the possibility of the vaccine increasing the risks of myocarditis. This rare heart condition causes inflammation of the heart muscles. Examples usually help, so we will explain how wagering requirements work for this promotion.  

“On Friday evening, the FDA informed Moderna that the agency requires additional time to evaluate recent international analyses of the risk of myocarditis after vaccination. The FDA notified Moderna that this review may not be completed before January 2022,” the statement from Moderna said. 

The company also restated its commitment to the safe use of the vaccine. “The safety of vaccine receivers is of supreme importance to Moderna. We are fully committed to working closely with the FDA to support their review and is grateful to them for their diligence.”

The Moderna vaccine has already found its way to several countries, but there have been increasing concerns over the vaccine adversely affecting the health of those in younger age groups. The possible increase in the risk of myocarditis has prompted countries like Japan, Sweden, and Finland to issue warnings against its use for men that fall in the age group of 18 to 30. 

Moderna, however, has quoted findings and statements by the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to claim that these occurrences have been “rare and generally mild”. 

“It is estimated that over 1.5 million adolescents have received the Moderna COVID-19 vaccine. If you make deposits with your credit card then this is your only welcome bonus option. To date, the observed rate of myocarditis reports in those less than 18 years of age and Moderna’s global safety database does not suggest an increased risk of myocarditis in this population,” the company statement revealed. Check your e-mail for the confirmation link.  

The delay is yet another in a string of postponements for vaccines for youngsters and adolescents. Federal health officials have regularly announced to the public that the benefits associated with the list of approved vaccines far outweigh the risks. At the same time, the FDA has also been closely monitoring the development of vaccines. Online Gambling Laws in Australia Despite the development stability and the gambling industry popularity, the country’s gambling legislation is rather complicated.  

Now, with several Nordic countries raising the alarm based on new information, the FDA is again reassessing the situation to guarantee the safety of U.S. citizens.

Related posts

Give Your Family The Good Taste Of Health With Healthy Crunch!

1 Mins read
We all know that healthy eating is essential, but it can be hard to find snacks that are good for you, and…

FDA panel votes unanimously in favor of COVID shots for youngest children

2 Mins read
Although COVID vaccines and boosters have been made widely available, a large demographic has not been eligible for this critical protection from…

Safe for Dogs, Neutralises Delta & Omicron Variants: What is Anocovax, India's First Covid Jab for Animals

1 Mins read
While there have been several debates over the passing of the virus to animals, several studies have shown that Covid-19 can spread…